Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Use of Kagocel® for the Prevention of ARVI and Influenza During the Epidemic Rise in the Incidence of Diseases in Adults

NCT04611061 is registered in ClinicalTrials.gov with Nearmedic Plus LLC as lead sponsor.

NCT NCT04611061
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04611061 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Use of Kagocel® for the Prevention of ARVI and Influenza During the Epidemic Rise in the Incidence of Diseases in Adults
Lead sponsor
Nearmedic Plus LLC
Phase
Observational
Overall status
Completed
Start date
October 2, 2017
Completion date
June 14, 2018
Enrollment
204 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute upper respiratory tract infection, influenza, respiratory viral infection